183
Views
15
CrossRef citations to date
0
Altmetric
Review

Overview of guidelines for the management of dyslipidemia: EU perspectives

, &
Pages 357-369 | Published online: 06 Sep 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Vicente Pallarés-Carratalá, Irene Bonig-Trigueros, Antonio Palazón-Bru, María José Esteban-Giner, Vicente Francisco Gil-Guillén & Vicente Giner-Galvañ. (2019) Clinical inertia in hypertension: a new holistic and practical concept within the cardiovascular continuum and clinical care process. Blood Pressure 28:4, pages 217-228.
Read now
Mostafa Alshamiri, Mahmood Mohammed Ali Ghanaim, Philip Barter, Kuan-Cheng Chang, Jian-Jun Li, Bien J Matawaran, Anwar Santoso, Sameh Shaheen, Ketut Suastika, Nuntakorn Thongtang & Ahmad KM Yusof. (2018) Expert opinion on the applicability of dyslipidemia guidelines in Asia and the Middle East. International Journal of General Medicine 11, pages 313-322.
Read now
Julie Rask Larsen, Lorena Dima, Christoph U. Correll & Peter Manu. (2018) The pharmacological management of metabolic syndrome. Expert Review of Clinical Pharmacology 11:4, pages 397-410.
Read now

Articles from other publishers (12)

Vijayakumar Natesan. 2023. Genome Editing in Cardiovascular and Metabolic Diseases. Genome Editing in Cardiovascular and Metabolic Diseases 255 273 .
Xinyi Cao, Wang Liao, Hui Xia, Shaokang Wang & Guiju Sun. (2022) The Effect of Resveratrol on Blood Lipid Profile: A Dose-Response Meta-Analysis of Randomized Controlled Trials. Nutrients 14:18, pages 3755.
Crossref
Sanjana Misra, Tanica Lyngdoh & Rubina Mulchandani. (2022) Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research. Indian Heart Journal 74:5, pages 341-350.
Crossref
Vivencio Barrios, Carlos Escobar, Javier Gamarra, Juan Carlos Obaya & Vicente Pallarés. (2021) Manejo del paciente con dislipidemia en España. Proyecto Cardio Right Care Control del Riesgo Cardiovascular. Medicina de Familia. SEMERGEN 47:1, pages 28-37.
Crossref
V. Giner Galvañ, I. Bonig Trigueros, L. Fácila Rubio, P. Morillas Blasco, S. Martínez Hervás, V. Pascual Fuster, F. Valls Roca, C. Soler Portmann, J.J. Tamarit García, V. Pallarés Carratalá, José María Cepeda Rodrigo, Juan Cosín Sales, Rafael Durá Belinchón, Enrique Gómez Segado, Saray Monleón Arenós, Carlos Morillas Ariño, Enrique Rodilla Sala, Eduardo Rovira Daudí & David Vicente Navarro. (2020) Have the Government's prescription algorithm and the 2013 American College of Cardiology/American Heart Association guidelines for managing dyslipidemia influenced the management of dyslipidemia? The MEJORALO-CV Project. Revista Clínica Española (English Edition) 220:5, pages 282-289.
Crossref
V. Giner Galvañ, I. Bonig Trigueros, L. Fácila Rubio, P. Morillas Blasco, S. Martínez Hervás, V. Pascual Fuster, F. Valls Roca, C. Soler Portmann, J.J. Tamarit García, V. Pallarés Carratalá, José María Cepeda Rodrigo, Juan Cosín Sales, Rafael Durá Belinchón, Enrique Gómez Segado, Saray Monleón Arenós, Carlos Morillas Ariño, Enrique Rodilla Sala, Eduardo Rovira Daudí & David Vicente Navarro. (2020) ¿Han influido el algoritmo de prescripción de la Administración y las guías de manejo de la dislipemia de la ACC/AHA 2013 en el manejo de la dislipemia? Proyecto MEJORA-LO CV. Revista Clínica Española 220:5, pages 282-289.
Crossref
M. Ciornei, Emese Orban & Remus Şipoş. (2020) Correlations of lipid metabolism with bone remodeling. Medic.ro 6:138, pages 28.
Crossref
Jesús Núñez-Cortés, Patricia Rodríguez-Fortúnez, Malena Melogno-Klinkas, Marta Rodríguez de Miguel, Susana Aceituno & Maria Luisa Orera-Peña. (2019) Management of atherogenic dyslipidemia according to current treatment guidelines: DESPEGA study in real clinical practice. Drugs & Therapy Perspectives 35:4, pages 192-199.
Crossref
Xu Lin, Cheng Peng, Jonathan Greenbaum, Zhang-Fang Li, Ke-Hao Wu, Zeng-Xin Ao, Tong Zhang, Jie Shen & Hong-Wen Deng. (2018) Identifying potentially common genes between dyslipidemia and osteoporosis using novel analytical approaches. Molecular Genetics and Genomics 293:3, pages 711-723.
Crossref
B. Kansu & D. Lang. (2017) Genetic polymorphisms as predictive markers for statin therapy: a route to improved cardiovascular patient outcomes?. Bioscience Horizons: The International Journal of Student Research 10.
Crossref
Binliang Liu, Zongbi Yi, Xiuwen Guan, Yi-Xin Zeng & Fei Ma. (2017) The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis. Breast Cancer Research and Treatment 164:1, pages 1-11.
Crossref
Ian M. Graham & Alberico L. Catapano. (2017) Management of Dyslipidemias in Europe and the USA: Same Evidence, Different Conclusions? Can We Find Common Ground?. Current Cardiology Reports 19:6.
Crossref